Matched Bargain Dealing Facility

RNS Number : 1488Q

Sportech PLC

16 October 2023

16 October 2023

SPORTECH PLC

(‘Sportech’ or the ‘Company’)

Matched Bargain Dealing Facility

Sportech, an international betting and technology business, reminds shareholders that the last day of dealings in Sportech will be today, 16 October 2023.

As noted in the Company’s announcement of 19 September 2023, the Company is expected to re-register as a private limited company with the name “Sportech Limited” and adopt its new articles of association in the week commencing 23 October 2023.

To facilitate future shareholder transactions in the Company’s ordinary shares, JP Jenkins has been appointed to provide a matched bargain facility. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).

The matched bargain facility is expected to operate for a minimum period of twelve months from 16 October 2023. Whilst the directors’ current intention is that the facility will continue beyond that time, shareholders should note that it could be withdrawn and, therefore, inhibit the ability of shareholders to trade their ordinary shares. Further details will be communicated to shareholders via the Company’s website at the relevant time.

Shareholders wishing to trade their ordinary shares can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.

The indicative pricing for the ordinary shares (ISIN: GB00BRV2F192), as well as the transaction history, will be available on the JP Jenkins website at https://jpjenkins.com.

For further information, please contact:

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END